Yatin Suneja
Stock Analyst at Guggenheim
(3.35)
# 984
Out of 4,954 analysts
133
Total ratings
49.58%
Success rate
2.28%
Average return
Main Sectors:
Stocks Rated by Yatin Suneja
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FBRX Forte Biosciences | Initiates: Buy | $75 | $11.27 | +565.48% | 1 | Aug 18, 2025 | |
| TRML Tourmaline Bio | Reiterates: Buy | $55 | $22.92 | +139.97% | 3 | Aug 14, 2025 | |
| REGN Regeneron Pharmaceuticals | Maintains: Buy | $810 → $815 | $598.16 | +36.25% | 7 | Aug 4, 2025 | |
| NBIX Neurocrine Biosciences | Maintains: Buy | $165 → $175 | $135.28 | +29.36% | 6 | Aug 1, 2025 | |
| ARGX argenx SE | Maintains: Buy | $1,060 → $1,070 | $662.39 | +61.54% | 12 | Aug 1, 2025 | |
| ABVX ABIVAX Société Anonyme | Maintains: Buy | $50 → $101 | $74.43 | +35.70% | 2 | Jul 23, 2025 | |
| LRMR Larimar Therapeutics | Reiterates: Buy | $26 | $3.69 | +604.61% | 6 | Jun 25, 2025 | |
| ALMS Alumis | Reinstates: Buy | $18 | $4.60 | +291.30% | 2 | Jun 10, 2025 | |
| ANAB AnaptysBio | Maintains: Buy | $54 → $90 | $20.37 | +341.83% | 13 | May 28, 2025 | |
| CABA Cabaletta Bio | Maintains: Buy | $23 → $25 | $1.60 | +1,462.50% | 5 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $29 | $12.87 | +125.33% | 1 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $12 | $10.95 | +9.64% | 4 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.99 | +653.77% | 2 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $10 | $0.90 | +1,013.59% | 5 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $0.68 | +925.34% | 1 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $14.82 | - | 8 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $84 | $23.65 | +255.18% | 1 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $45 | $16.97 | +165.17% | 3 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.64 | - | 2 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $45 | $11.35 | +296.48% | 3 | Jan 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $20 | $24.79 | -19.32% | 6 | Jan 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.87 | - | 2 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $65 | $16.78 | +287.37% | 1 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $10.51 | - | 3 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $72 → $90 | $22.02 | +308.72% | 5 | Feb 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $125 | $117.05 | +6.80% | 8 | Feb 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $16 | $11.82 | +35.36% | 2 | Nov 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $70 → $77 | $53.97 | +42.67% | 3 | Nov 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.23 | - | 3 | Jul 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $49 | $38.21 | +28.24% | 2 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $52 → $55 | $11.60 | +374.14% | 2 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $270 → $350 | $139.15 | +151.53% | 3 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.61 | - | 3 | Oct 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $14.48 | +65.75% | 1 | May 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $29 → $34 | $105.45 | -67.76% | 2 | Jan 14, 2020 |
Forte Biosciences
Aug 18, 2025
Initiates: Buy
Price Target: $75
Current: $11.27
Upside: +565.48%
Tourmaline Bio
Aug 14, 2025
Reiterates: Buy
Price Target: $55
Current: $22.92
Upside: +139.97%
Regeneron Pharmaceuticals
Aug 4, 2025
Maintains: Buy
Price Target: $810 → $815
Current: $598.16
Upside: +36.25%
Neurocrine Biosciences
Aug 1, 2025
Maintains: Buy
Price Target: $165 → $175
Current: $135.28
Upside: +29.36%
argenx SE
Aug 1, 2025
Maintains: Buy
Price Target: $1,060 → $1,070
Current: $662.39
Upside: +61.54%
ABIVAX Société Anonyme
Jul 23, 2025
Maintains: Buy
Price Target: $50 → $101
Current: $74.43
Upside: +35.70%
Larimar Therapeutics
Jun 25, 2025
Reiterates: Buy
Price Target: $26
Current: $3.69
Upside: +604.61%
Alumis
Jun 10, 2025
Reinstates: Buy
Price Target: $18
Current: $4.60
Upside: +291.30%
AnaptysBio
May 28, 2025
Maintains: Buy
Price Target: $54 → $90
Current: $20.37
Upside: +341.83%
Cabaletta Bio
May 16, 2025
Maintains: Buy
Price Target: $23 → $25
Current: $1.60
Upside: +1,462.50%
May 9, 2025
Maintains: Buy
Price Target: $32 → $29
Current: $12.87
Upside: +125.33%
May 2, 2025
Maintains: Buy
Price Target: $18 → $12
Current: $10.95
Upside: +9.64%
Mar 26, 2025
Reiterates: Buy
Price Target: $15
Current: $1.99
Upside: +653.77%
Mar 26, 2025
Maintains: Buy
Price Target: $7 → $10
Current: $0.90
Upside: +1,013.59%
Mar 21, 2025
Reiterates: Buy
Price Target: $7
Current: $0.68
Upside: +925.34%
Mar 20, 2025
Reiterates: Buy
Price Target: n/a
Current: $14.82
Upside: -
Mar 12, 2025
Reiterates: Buy
Price Target: $84
Current: $23.65
Upside: +255.18%
Mar 12, 2025
Reiterates: Buy
Price Target: $45
Current: $16.97
Upside: +165.17%
Mar 10, 2025
Downgrades: Neutral
Price Target: n/a
Current: $1.64
Upside: -
Jan 3, 2025
Upgrades: Buy
Price Target: $45
Current: $11.35
Upside: +296.48%
Jan 3, 2025
Downgrades: Neutral
Price Target: $20
Current: $24.79
Upside: -19.32%
Dec 12, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.87
Upside: -
Oct 25, 2024
Maintains: Buy
Price Target: $50 → $65
Current: $16.78
Upside: +287.37%
May 10, 2024
Downgrades: Neutral
Price Target: n/a
Current: $10.51
Upside: -
Feb 27, 2024
Maintains: Buy
Price Target: $72 → $90
Current: $22.02
Upside: +308.72%
Feb 21, 2024
Maintains: Buy
Price Target: $110 → $125
Current: $117.05
Upside: +6.80%
Nov 15, 2023
Maintains: Buy
Price Target: $17 → $16
Current: $11.82
Upside: +35.36%
Nov 15, 2023
Maintains: Buy
Price Target: $70 → $77
Current: $53.97
Upside: +42.67%
Jul 17, 2023
Downgrades: Neutral
Price Target: n/a
Current: $5.23
Upside: -
Jun 15, 2023
Reiterates: Buy
Price Target: $49
Current: $38.21
Upside: +28.24%
May 18, 2023
Maintains: Buy
Price Target: $52 → $55
Current: $11.60
Upside: +374.14%
May 1, 2023
Upgrades: Buy
Price Target: $270 → $350
Current: $139.15
Upside: +151.53%
Oct 14, 2022
Downgrades: Neutral
Price Target: n/a
Current: $0.61
Upside: -
May 31, 2022
Initiates: Buy
Price Target: $24
Current: $14.48
Upside: +65.75%
Jan 14, 2020
Maintains: Buy
Price Target: $29 → $34
Current: $105.45
Upside: -67.76%